Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis

James D. Finklea, Gul Khan, Sheree Thomas, Juhee Song, Dennis Myers, Alejandro C. Arroliga

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: In-hospital and long term outcomes of patients admitted to the hospital for acute exacerbation of bronchiectasis (AEB) has been evaluated in only a limited fashion. The resulting debilitation after an AEB can increase mortality. This study aims to evaluate the factors associated with mortality in patients admitted with an acute exacerbation of bronchiectasis (AEB). Methods: All charts of the patients admitted between 2003 and 2006 with an AEB were reviewed through an electronic database. Demographics, sputum cultures, pulmonary functions tests and other factors associated with long-term mortality were examined. The social security death index was used to determine long term mortality (http://ssdi.genealogy.rootsweb.com). Results: Forty-three patients (13 men and 30 women) with a mean age of 71.8 ± 11.8 were studied. The hospital mortality was 9% and one-year mortality was 30% with a median survival of 46.6 months. Variables associated with mortality were male gender (female vs. male (HR), 0.36; (CI), 0.14-0.98; p = 0.045), use of systemic steroids (with vs. without steroids HR, 3.12; CI 1.08-9.02; p = 0.036), decreased FEV1.0% predicted (HR, 0.96; CI 0.92-0.999; p = 0.042), elevated creatinine (HR, 2.36; CI 1.093-5.10; p = 0.029), history of smoking (HR, 0.283; CI 0.097-0.825; p = 0.021), and mechanical ventilation (HR, 66.011; CI 6.64-656.76; p = 0.0004). Conclusions: Male gender, elevated creatinine, decreased FEV1.0% predicted, mechanical ventilation, history of smoking, and acute use of systemic steroids during the hospitalization were associated with an increased risk of mortality.

Original languageEnglish (US)
Pages (from-to)816-821
Number of pages6
JournalRespiratory Medicine
Volume104
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Bronchiectasis
Mortality
Steroids
Artificial Respiration
Creatinine
Smoking
Genealogy and Heraldry
Social Security
Respiratory Function Tests
Hospital Mortality
Sputum
Hospitalization
Demography
Databases
Survival

Keywords

  • Bronchiectasis
  • FEV% predicted
  • Mortality
  • Systemic steroids

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. / Finklea, James D.; Khan, Gul; Thomas, Sheree; Song, Juhee; Myers, Dennis; Arroliga, Alejandro C.

In: Respiratory Medicine, Vol. 104, No. 6, 06.2010, p. 816-821.

Research output: Contribution to journalArticle

Finklea, James D. ; Khan, Gul ; Thomas, Sheree ; Song, Juhee ; Myers, Dennis ; Arroliga, Alejandro C. / Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. In: Respiratory Medicine. 2010 ; Vol. 104, No. 6. pp. 816-821.
@article{b94410835b7c4f918b1f2090e2aa1c6f,
title = "Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis",
abstract = "Background: In-hospital and long term outcomes of patients admitted to the hospital for acute exacerbation of bronchiectasis (AEB) has been evaluated in only a limited fashion. The resulting debilitation after an AEB can increase mortality. This study aims to evaluate the factors associated with mortality in patients admitted with an acute exacerbation of bronchiectasis (AEB). Methods: All charts of the patients admitted between 2003 and 2006 with an AEB were reviewed through an electronic database. Demographics, sputum cultures, pulmonary functions tests and other factors associated with long-term mortality were examined. The social security death index was used to determine long term mortality (http://ssdi.genealogy.rootsweb.com). Results: Forty-three patients (13 men and 30 women) with a mean age of 71.8 ± 11.8 were studied. The hospital mortality was 9{\%} and one-year mortality was 30{\%} with a median survival of 46.6 months. Variables associated with mortality were male gender (female vs. male (HR), 0.36; (CI), 0.14-0.98; p = 0.045), use of systemic steroids (with vs. without steroids HR, 3.12; CI 1.08-9.02; p = 0.036), decreased FEV1.0{\%} predicted (HR, 0.96; CI 0.92-0.999; p = 0.042), elevated creatinine (HR, 2.36; CI 1.093-5.10; p = 0.029), history of smoking (HR, 0.283; CI 0.097-0.825; p = 0.021), and mechanical ventilation (HR, 66.011; CI 6.64-656.76; p = 0.0004). Conclusions: Male gender, elevated creatinine, decreased FEV1.0{\%} predicted, mechanical ventilation, history of smoking, and acute use of systemic steroids during the hospitalization were associated with an increased risk of mortality.",
keywords = "Bronchiectasis, FEV{\%} predicted, Mortality, Systemic steroids",
author = "Finklea, {James D.} and Gul Khan and Sheree Thomas and Juhee Song and Dennis Myers and Arroliga, {Alejandro C.}",
year = "2010",
month = "6",
doi = "10.1016/j.rmed.2009.11.021",
language = "English (US)",
volume = "104",
pages = "816--821",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis

AU - Finklea, James D.

AU - Khan, Gul

AU - Thomas, Sheree

AU - Song, Juhee

AU - Myers, Dennis

AU - Arroliga, Alejandro C.

PY - 2010/6

Y1 - 2010/6

N2 - Background: In-hospital and long term outcomes of patients admitted to the hospital for acute exacerbation of bronchiectasis (AEB) has been evaluated in only a limited fashion. The resulting debilitation after an AEB can increase mortality. This study aims to evaluate the factors associated with mortality in patients admitted with an acute exacerbation of bronchiectasis (AEB). Methods: All charts of the patients admitted between 2003 and 2006 with an AEB were reviewed through an electronic database. Demographics, sputum cultures, pulmonary functions tests and other factors associated with long-term mortality were examined. The social security death index was used to determine long term mortality (http://ssdi.genealogy.rootsweb.com). Results: Forty-three patients (13 men and 30 women) with a mean age of 71.8 ± 11.8 were studied. The hospital mortality was 9% and one-year mortality was 30% with a median survival of 46.6 months. Variables associated with mortality were male gender (female vs. male (HR), 0.36; (CI), 0.14-0.98; p = 0.045), use of systemic steroids (with vs. without steroids HR, 3.12; CI 1.08-9.02; p = 0.036), decreased FEV1.0% predicted (HR, 0.96; CI 0.92-0.999; p = 0.042), elevated creatinine (HR, 2.36; CI 1.093-5.10; p = 0.029), history of smoking (HR, 0.283; CI 0.097-0.825; p = 0.021), and mechanical ventilation (HR, 66.011; CI 6.64-656.76; p = 0.0004). Conclusions: Male gender, elevated creatinine, decreased FEV1.0% predicted, mechanical ventilation, history of smoking, and acute use of systemic steroids during the hospitalization were associated with an increased risk of mortality.

AB - Background: In-hospital and long term outcomes of patients admitted to the hospital for acute exacerbation of bronchiectasis (AEB) has been evaluated in only a limited fashion. The resulting debilitation after an AEB can increase mortality. This study aims to evaluate the factors associated with mortality in patients admitted with an acute exacerbation of bronchiectasis (AEB). Methods: All charts of the patients admitted between 2003 and 2006 with an AEB were reviewed through an electronic database. Demographics, sputum cultures, pulmonary functions tests and other factors associated with long-term mortality were examined. The social security death index was used to determine long term mortality (http://ssdi.genealogy.rootsweb.com). Results: Forty-three patients (13 men and 30 women) with a mean age of 71.8 ± 11.8 were studied. The hospital mortality was 9% and one-year mortality was 30% with a median survival of 46.6 months. Variables associated with mortality were male gender (female vs. male (HR), 0.36; (CI), 0.14-0.98; p = 0.045), use of systemic steroids (with vs. without steroids HR, 3.12; CI 1.08-9.02; p = 0.036), decreased FEV1.0% predicted (HR, 0.96; CI 0.92-0.999; p = 0.042), elevated creatinine (HR, 2.36; CI 1.093-5.10; p = 0.029), history of smoking (HR, 0.283; CI 0.097-0.825; p = 0.021), and mechanical ventilation (HR, 66.011; CI 6.64-656.76; p = 0.0004). Conclusions: Male gender, elevated creatinine, decreased FEV1.0% predicted, mechanical ventilation, history of smoking, and acute use of systemic steroids during the hospitalization were associated with an increased risk of mortality.

KW - Bronchiectasis

KW - FEV% predicted

KW - Mortality

KW - Systemic steroids

UR - http://www.scopus.com/inward/record.url?scp=77952322348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952322348&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2009.11.021

DO - 10.1016/j.rmed.2009.11.021

M3 - Article

C2 - 20363606

AN - SCOPUS:77952322348

VL - 104

SP - 816

EP - 821

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 6

ER -